TY - JOUR AU - Graham, D. K. AU - DeRyckere, D. AU - Davies, K. D. AU - Earp, H. S. PY - 2014 DA - 2014// TI - The TAM family: phosphatidylserine-sensing receptor tyrosine kinases gone awry in cancer JO - Nat Rev Cancer VL - 14 UR - https://doi.org/10.1038/nrc3847 DO - 10.1038/nrc3847 ID - Graham2014 ER - TY - JOUR AU - Ishikawa, M. AU - Sonobe, M. AU - Nakayama, E. AU - Kobayashi, M. AU - Kikuchi, R. AU - Kitamura, J. PY - 2013 DA - 2013// TI - Higher expression of receptor tyrosine kinase Axl, and differential expression of its ligand, Gas6, predict poor survival in lung adenocarcinoma patients JO - Ann Surg Oncol VL - 20 UR - https://doi.org/10.1245/s10434-012-2795-3 DO - 10.1245/s10434-012-2795-3 ID - Ishikawa2013 ER - TY - JOUR AU - Zhang, Z. AU - Lee, J. C. AU - Lin, L. AU - Olivas, V. AU - Au, V. AU - LaFramboise, T. PY - 2012 DA - 2012// TI - Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer JO - Nat Genet VL - 44 UR - https://doi.org/10.1038/ng.2330 DO - 10.1038/ng.2330 ID - Zhang2012 ER - TY - JOUR AU - Skinner, H. D. AU - Giri, U. AU - Yang, L. P. AU - Kumar, M. AU - Liu, Y. AU - Story, M. D. PY - 2017 DA - 2017// TI - Integrative analysis identifies a novel AXL-PI3 kinase-PD-L1 signaling Axis associated with radiation resistance in head and neck Cancer JO - Clin Cancer Res VL - 23 UR - https://doi.org/10.1158/1078-0432.CCR-16-2586 DO - 10.1158/1078-0432.CCR-16-2586 ID - Skinner2017 ER - TY - JOUR AU - Aust, S. AU - Felix, S. AU - Auer, K. AU - Bachmayr-Heyda, A. AU - Kenner, L. AU - Dekan, S. PY - 2017 DA - 2017// TI - Absence of PD-L1 on tumor cells is associated with reduced MHC I expression and PD-L1 expression increases in recurrent serous ovarian cancer JO - Sci Rep VL - 7 UR - https://doi.org/10.1038/srep42929 DO - 10.1038/srep42929 ID - Aust2017 ER - TY - JOUR AU - Nagarsheth, N. AU - Wicha, M. S. AU - Zou, W. PY - 2017 DA - 2017// TI - Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy JO - Nat Rev Immunol VL - 17 UR - https://doi.org/10.1038/nri.2017.49 DO - 10.1038/nri.2017.49 ID - Nagarsheth2017 ER - TY - JOUR AU - Chen, N. AU - Fang, W. AU - Zhan, J. AU - Hong, S. AU - Tang, Y. AU - Kang, S. PY - 2015 DA - 2015// TI - Upregulation of PD-L1 by EGFR activation mediates the immune escape in EGFR-driven NSCLC: implication for optional immune targeted therapy for NSCLC patients with EGFR mutation JO - J Thorac Oncol VL - 10 UR - https://doi.org/10.1097/JTO.0000000000000500 DO - 10.1097/JTO.0000000000000500 ID - Chen2015 ER - TY - JOUR AU - Hugo, W. AU - Zaretsky, J. M. AU - Sun, L. AU - Song, C. AU - Moreno, B. H. AU - Hu-Lieskovan, S. PY - 2016 DA - 2016// TI - Genomic and transcriptomic features of response to anti-PD-1 therapy in metastatic melanoma JO - Cell VL - 165 UR - https://doi.org/10.1016/j.cell.2016.02.065 DO - 10.1016/j.cell.2016.02.065 ID - Hugo2016 ER - TY - JOUR AU - Lee, C. K. AU - Man, J. AU - Lord, S. AU - Links, M. AU - Gebski, V. AU - Mok, T. PY - 2017 DA - 2017// TI - Checkpoint inhibitors in metastatic EGFR-mutated non-small cell lung Cancer-a meta-analysis JO - J Thorac Oncol VL - 12 UR - https://doi.org/10.1016/j.jtho.2016.10.007 DO - 10.1016/j.jtho.2016.10.007 ID - Lee2017 ER -